PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$28.57 USD
+3.08 (12.08%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $28.58 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.41 |
EPS Last Quarter | -1.20 |
Last EPS Surprise | 0.83% |
ABR | 2.84 |
Earnings ESP
|
23.28% |
---|---|
Current Year | -5.87 |
Next Year | -5.17 |
EPS (TTM) | -5.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 150.72M | 149.05M | 607.31M | 625.74M |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 177.00M | 179.50M | 680.24M | 806.37M |
Low Estimate | 118.50M | 113.90M | 469.70M | 332.80M |
Year ago Sales | 213.81M | 196.58M | 937.82M | 607.31M |
Year over Year Growth Est. | -29.51% | -24.18% | -35.24% | 3.04% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.41 | -1.69 | -5.87 | -5.17 |
# of Estimates | 7 | 6 | 9 | 8 |
Most Recent Consensus | -1.39 | -1.56 | -5.41 | -5.01 |
High Estimate | -1.01 | -1.30 | -3.65 | -1.98 |
Low Estimate | -1.95 | -2.26 | -8.45 | -9.16 |
Year ago EPS | -2.66 | -1.76 | -3.62 | -5.87 |
Year over Year Growth Est. | 46.99% | 3.98% | -62.15% | 12.04% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 1 | 1 | 2 | 2 |
Up Last 60 Days | 2 | 3 | 5 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 2 | 4 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.41 | -1.69 | -5.87 | -5.17 |
7 Days Ago | -1.51 | -1.72 | -5.94 | -5.34 |
30 Days Ago | -1.51 | -1.72 | -5.95 | -5.36 |
60 Days Ago | -1.58 | -1.66 | -6.00 | -4.98 |
90 Days Ago | -1.63 | -1.73 | -5.88 | -4.69 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.09 | -1.40 | -5.92 | -4.88 |
Zacks Consensus Estimate | -1.41 | -1.69 | -5.87 | -5.17 |
Earnings ESP | 23.28% | 17.00% | -0.71% | 5.64% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.20 | -0.24 | -1.76 | -2.66 | NA |
Estimate | -1.21 | 0.29 | -0.85 | -1.58 | NA |
Difference | 0.01 | -0.53 | -0.91 | -1.08 | -0.63 |
Surprise | 0.83% | -182.76% | -107.06% | -68.35% | -89.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more